Successfuly combating gynocomastia with an extremly low dose of topical Tamoxifen 6/24/2025
Using a low dose of topical Tamoxifen effectively reduces gynecomastia caused by finasteride, with minimal side effects. The solution involves mixing Tamoxifen with ethanol and propylene glycol, applied daily to the chest.
View this post in the Community β
Similar Community Posts Join
5 / 5 resultscommunity Fin, Testorone and Gyno Theory
The conversation discusses managing gynecomastia symptoms potentially caused by finasteride use, with treatments including reducing finasteride dosage, using DIM, ashwagandha, tamoxifen, epistane, and arimistane. Users share experiences and advice on balancing testosterone and estrogen levels to address symptoms.
community Got Gynecomastia from Dutasteride, now what?
The user experienced gynecomastia after switching from finasteride to dutasteride and is considering stopping dutasteride or having surgery to remove the gland. They are advised to stop dutasteride, consider surgery, and explore medications like raloxifene or tamoxifen to manage symptoms.
community 1.5 years Finasteride every day and twice a week Ketoconazole, 0.5 years 50mg RU58841 every day
The user used Finasteride daily and Ketoconazole twice a week for 1.5 years, and RU58841 daily for 0.5 years, which improved hair thickness but caused slight gynecomastia. They are considering using SERMs like tamoxifen and raloxifene to manage side effects and are exploring other treatments like oral minoxidil.
community Gyno & testoterone level
Switching from finasteride to dutasteride and back to finasteride led to gynecomastia and fatigue, likely due to hormonal imbalances. Suggested treatments include Tamoxifen, Raloxifene, or low-dose Anastrozole, with a recommendation to test testosterone and estradiol levels.
community Want to maximize hair regrowth and maintenance while avoiding gyno
To minimize the risk of gynecomastia while maximizing hair regrowth, some suggest using finasteride six times a week and dutasteride once, while others recommend using raloxifene or tamoxifen. Concerns about gynecomastia are common, with some users experiencing flare-ups despite low estrogen levels, and others advising caution and considering surgery if necessary.
Related Research
6 / 6 resultsresearch Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
This paper discusses the adverse effects of finasteride, including sexual dysfunction and depression, and suggests that treatment customization based on individual factors like hand preference and sexual orientation could improve outcomes and reduce these side effects.
research Potential targets in the discovery of new hair growth promoters for androgenic alopecia
This review discusses current therapeutic targets and treatments for androgenic alopecia but reports no clinical results; the authors highlight the challenge of developing multi-target drugs for effective treatment.
research Tamoxifen for flutamide/finasteride-induced gynecomastia
This study found that low-dose tamoxifen may effectively treat painful gynecomastia in patients receiving flutamide and finasteride for advanced prostate cancer.
research Research progress on drug-induced gynecomastia
This review describes drug-induced gynecomastia, which results from an imbalance between estrogen and androgen action, listing potential treatments but no new clinical results.
research Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia
This study suggests that continuing finasteride therapy after mastectomy does not significantly affect gynecomastia recurrence in men taking finasteride for alopecia.
research Persistent Gynecomastia due to Short-term Low-dose Finasteride for Androgenetic Alopecia
This case report highlights a persistent gynecomastia in a young man following low-dose finasteride, suggesting that the incidence may be underreported and calls for patient counseling and early intervention.